30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Connie Matsui

Track

Insider profile

Currently holds a position at Halozyme Therapeutics Inc

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 85% 68% 82%
Transactions
8 12% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Chairman of the Board Halozyme Therapeutics Inc Feb. 1, 2016 -
Independent Director Halozyme Therapeutics Inc July 27, 2006 - Feb. 1, 2016
Connie Matsui's trades of Sutro Biopharma Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-16 2025-10-15
B Purchase
40,215 -4.2%
13.44
US$3,898,146 		40,215 -4.2% 13.44 US$3,898,146
2021-11-05 2021-11-05
S Sale
98,372 +13.6%
425.74
US$3,621,219 		98,372 +13.6% 425.74 US$3,621,219
2021-11-05 2021-11-05
S Sale
43,639 +14.7%
179.05
US$2,880,906 		43,639 +14.7% 179.05 US$2,880,906
2020-09-14 2020-09-11
S Sale
32,000 -12.9%
27.06
US$865,792 		32,000 -12.9% 27.06 US$865,792
2004-05-19 2004-05-18
US Biogen Inc (BIIB)
S Sale
20,000 -18.5%
59.05
US$1,181,000 		20,000 -18.5% 59.05 US$1,181,000
2004-05-19 2004-05-18
US Biogen Inc (BIIB)
S Sale
10,000 -8.5%
59.09
US$590,900 		10,000 -8.5% 59.09 US$590,900
2004-05-19 2004-05-18
US Biogen Inc (BIIB)
S Sale
10,000 -7.8%
59.03
US$590,300 		10,000 -7.8% 59.03 US$590,300
2004-05-19 2004-05-18
US Biogen Inc (BIIB)
S Sale
20,000 -13.5%
59.02
US$1,180,400 		20,000 -13.5% 59.02 US$1,180,400